Alazocine
| Systematic (IUPAC) name | |
|---|---|
| (2R,6R,11R)- 6,11-dimethyl- 3-prop- 2-en- 1-yl- 1,2,3,4,5,6-hexahydro- 2,6-methano- 3-benzazocin- 8-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Routes | ? |
| Identifiers | |
| CAS number | 14198-28-8 |
| ATC code | None |
| PubChem | CID 3036246 |
| ChemSpider | 2300306 |
| ChEMBL | CHEMBL330376 |
| Chemical data | |
| Formula | C17H23NO |
| Mol. mass | 257.37 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Alazocine ((-)-SKF-10,047), or (-)-N-allylnormetazocine ((-)-ANMC), was the first drug discovered to act as a σ1 receptor agonist (Ki = 24 nM).[1][2][3] It has no significant affinity for the σ2 receptor.[3] Alazocine also acts as a κ-opioid receptor agonist (Ki = 0.4 nM), and to a much lesser extent, as an NMDA receptor antagonist (Ki = 587 nM).[3][4]
[edit] See also
[edit] References
- ^ Iwamoto ET (February 1981). "Pharmacologic effects of N-allylnormetazocine (SKF-10047)". NIDA research monograph 34: 82–8. PMID 6783955.
- ^ Shearman GT, Herz A (August 1982). "Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat". European journal of pharmacology 82 (3–4): 167–72. doi:10.1016/0014-2999(82)90506-4. PMID 6290235.
- ^ a b c Chou YC, Liao JF, Chang WY, Lin MF, Chen CF (March 1999). "Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan". Brain Research 821 (2): 516–9. doi:10.1016/S0006-8993(99)01125-7. PMID 10064839. http://linkinghub.elsevier.com/retrieve/pii/S0006-8993(99)01125-7.
- ^ Gharagozlou P, Hashemi E, DeLorey TM, Clark JD, Lameh J (2006). "Pharmacological profiles of opioid ligands at Kappa opioid receptors". BMC Pharmacology 6: 3. doi:10.1186/1471-2210-6-3. PMC 1403760. PMID 16433932. http://www.biomedcentral.com/1471-2210/6/3.
|
|
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

